Evidence map›Paper›PMID 22420709›Full record

ReviewBritish journal of clinical pharmacology2012

Local formularies.

D John M Reynolds, Olubunmi Fajemisin, Sara Wilds

Abstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Canadian list of essential medications: Potential and uncertainties.Canadian family physician Medecin de famille canadien · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The science of prescribing.British journal of clinical pharmacology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

D John M ReynoldsConsultant Physician and Clinical Pharmacologist, Oxford University Hospitals NHS Trust, UK. john.reynolds@ouh.nhs.uk
Olubunmi Fajemisin
Sara Wilds

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread availability of authoritative guidance on prescribing from a wide variety of international and national bodies calls into question the need for additional local formulary advice. This article describes contemporary local formulary management in the United Kingdom and discusses the areas where local decision making remains valuable. Local formularies can fulfil important roles which justify their continued existence, including ensuring local ownership and acceptance of advice, rapid dissemination of information, responsiveness to local circumstances and service design, sensitivity to local pricing arrangements and close professional links with commissioners, pharmacists and prescribers.

Indexed as

Decision MakingDrug CostsDrug PrescriptionsFormularies, Hospital as TopicHumansUnited Kingdom

Identifiers

PMID22420709
PMCPMC3477332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.